119th Congress
H.R. 1060
Modern Authentication of Pharmaceuticals Act of 2025
- Introduced
- In committee
- Passed House
- Passed Senate
- To President
- Became law
- Sponsor
- Donald G. Davis(D-NC)
- Introduced
- Feb 6, 2025
- Policy area
- Health
- Committees
- House Committee on Energy and Commerce
- Official text
- Introduced in House · Congress.gov page
Cosponsors (3)
Original cosponsors (2)
- Don Bacon (R-NE)
- John H. Rutherford (R-FL)
Added later (1)
- Brian K. Fitzpatrick (R-PA) · Mar 11, 2025
Summary
Summary by the Congressional Research Service· describes the “Introduced in House” version
Modern Authentication of Pharmaceuticals Act of 2025
This bill requires each dose of a pharmaceutical product that is a controlled substance and that is taken orally in solid form (i.e., pills) to include a physical chemical identifier. (Physical chemical identifiers are substances that possess a unique physical or chemical property, such as inks, pigments, flavors, and molecular taggants, that unequivocally identify and authenticate a drug or dosage.) Under the bill, physical chemical identifiers must be included in or on the product and must be machine readable.
The bill applies to products manufactured beginning five years after the bill's enactment.
Roll-call votes
No recorded votes on this bill.
Actions
- Feb 6, 2025 · House
Referred to the House Committee on Energy and Commerce. - Feb 6, 2025
Introduced in House - Feb 6, 2025
Sponsor introductory remarks on measure. (CR H519)